Failure in DDR can lead to genomic instability, accumulation of mutations, and cancer development. For instance, mutations in BRCA1 or BRCA2, key proteins in HR, are linked to a higher risk of breast and ovarian cancers. Defective DDR can also contribute to aging and neurodegenerative diseases.
